Medication info
Traritine Tablet (Linagliptin)

Traritine Tablet (Linagliptin)

Prescription medicationTablet
Ingredient · strength
Linagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pink, biconvex, round film-coated tablet
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201803132 · Approved 2018.07.30 · Insurance code 671807650

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used together with dietary therapy and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications to effectively manage blood sugar levels.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5mg once daily. It may be taken with or without food. When administered concomitantly with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used in patients with a known allergy to the active ingredient or any other component of this drug. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is required when taking this medication in combination with insulin or sulfonylurea drugs, as this may result in a risk of hypoglycemia. Adjustment of dosage may be necessary due to the increased risk of hypoglycemia when used in combination. Patients with heart failure should use this medication with caution, and if symptoms of pancreatitis occur, they should immediately stop taking it and consult a doctor. If continuous and severe abdominal pain occurs during the treatment, pancreatitis should be suspected. A skin condition known as bullous pemphigoid may occur, so if blisters or skin rash appear, notifying a doctor immediately is necessary. Various adverse reactions, including hypoglycemia, have been reported with this medication, particularly when used in combination with other diabetes treatments, where hypoglycemic symptoms may be more common. Severe joint pain may occur, and drug discontinuation should be considered if symptoms appear. Use during pregnancy or breastfeeding is not recommended; if pregnant or nursing, consultation with a doctor is essential before taking this medication. The safety and efficacy of this medication have not been established in children and adolescents, hence its use is not recommended in these populations. Elderly patients may use it without special dose adjustments, and patients with impaired kidney or liver function can also take it without dosage adjustment. In case of overdose, the absorption of the drug in the gastrointestinal tract should be reduced, symptoms should be observed, and appropriate treatment should be administered as necessary. This medication should be kept out of reach of children, and transferring it to another container is not advisable for safety and quality maintenance.

Side effects

Hypoglycemia, hypertriglyceridemia, hyperlipidemia, cough, pancreatitis, constipation, oral ulcer formation, rash, vesicular pemphigoid-like lesions, severe joint pain with disability, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, epigastric pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorders, Alzheimer's dementia, chest pain, fever, facial edema, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, pneumonia, dyspnea, abdominal pain, gastrointestinal disorders, irritable bowel syndrome, burning mouth syndrome, colitis, abdominal discomfort, dysphagia, gastric ulcer, gum bleeding, tooth loss, hemorrhoids, lower abdominal pain, diarrhea, vomiting, gastritis, gastrointestinal disorders, acute pyelonephritis, bronchitis, leukoplakia, rhinitis, soft tissue infection, pharyngitis, vestibular neuronitis, scrub typhus, periodontitis, sepsis, tonsillitis, laryngitis, viral upper respiratory infection, pneumonia, tonsillitis, decreased appetite, hypercholesterolemia, insufficient control of diabetes, malnutrition, hyponatremia, dehydration, hyperglycemia, headache, sensory abnormalities, post-herpetic neuralgia, hemiplegia, syncope, drowsiness, chest discomfort, asthenia, pain, nosebleed, oropharyngeal pain, vocal cord dysfunction, allergic rhinitis, exertional dyspnea, wet cough, asthma, rhinorrhea, pulmonary mass, joint pain, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, positive urine leukocytes, reduced hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase activity in blood, increased ALT, increased triglycerides in blood, male pattern baldness, hyperhidrosis, hair loss, skin lesions, dermatitis, anxiety, affective disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eyes, glaucoma, cataracts, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, fatty liver disease, cholelithiasis, hearing loss, erectile dysfunction, goiter, anemia, nausea, diarrhea, gastroesophageal reflux disease, pruritus, hypertension, benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage helps maintain the effectiveness of the medication and prevents degradation.

Appearance and packaging

Appearance

Pink, biconvex, round film-coated tablet

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.